TCMD icon

Tactile Systems Technology

9.95 USD
-0.09
0.90%
At close Jun 12, 4:00 PM EDT
After hours
10.00
+0.05
0.50%
1 day
-0.90%
5 days
-2.64%
1 month
2.37%
3 months
-24.96%
6 months
-45.12%
Year to date
-41.88%
1 year
-17.01%
5 years
-75.59%
10 years
-10.20%
 

About: Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Employees: 1,037

0
Funds holding %
of 7,295 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

844% more call options, than puts

Call options by funds: $1.89M | Put options by funds: $200K

3.42% more ownership

Funds ownership: 87.9% [Q4 2024] → 91.32% (+3.42%) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 22

1% less funds holding

Funds holding: 141 [Q4 2024] → 139 (-2) [Q1 2025]

15% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 52

21% less capital invested

Capital invested by funds: $361M [Q4 2024] → $285M (-$76.6M) [Q1 2025]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$14
41%
upside
Avg. target
$14
41%
upside
High target
$14
41%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Piper Sandler
Adam Maeder
41%upside
$14
Neutral
Downgraded
6 May 2025

Financial journalist opinion

Neutral
GlobeNewsWire
1 week ago
New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors
Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors
New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors
Neutral
GlobeNewsWire
3 weeks ago
Tactile Medical to Present at Upcoming Investor Conferences in June
MINNEAPOLIS, May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will be participating in two upcoming investor conferences. Tactile Medical is scheduled to present at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 3:20 p.m. CST and at the Jefferies Global Healthcare Conference in New York on Wednesday, June 4, 2025, at 2:35 p.m. EST.
Tactile Medical to Present at Upcoming Investor Conferences in June
Negative
Benzinga
1 month ago
Tactile Systems Stock Tumbles As Q1 Earnings Fall Short Of Expectations
Tactile Systems Technology, Inc. TCMD traded lower on Tuesday after the company's Q1 earnings missed Wall Street expectations on Monday.
Tactile Systems Stock Tumbles As Q1 Earnings Fall Short Of Expectations
Neutral
Seeking Alpha
1 month ago
Tactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call Transcript
Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q1 2025 Earnings Conference Call May 5, 2025 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Margaret Kaczor Andrew - William Blair Ryan Zimmerman - BTIG Anderson Schock - B. Riley Securities Operator Welcome, ladies and gentlemen, to the First Quarter 2025 Earnings Conference Call for Tactile Medical.
Tactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
Tactile Systems Technology (TCMD) Reports Q1 Loss, Lags Revenue Estimates
Tactile Systems Technology (TCMD) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.05 per share a year ago.
Tactile Systems Technology (TCMD) Reports Q1 Loss, Lags Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results
MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2025.
Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results
Neutral
GlobeNewsWire
1 month ago
Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025
MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2025 financial results will be released after the market closes on Monday, May 5, 2025.
Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025
Positive
Benzinga
3 months ago
Top 3 Health Care Stocks You'll Regret Missing This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Top 3 Health Care Stocks You'll Regret Missing This Quarter
Neutral
GlobeNewsWire
3 months ago
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
MINNEAPOLIS, March 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, which is being virtually held from March 17th – 20th. Management will participate in a virtual presentation on Tuesday, March 18th at 12:00 p.m. Eastern Time.
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Neutral
Seeking Alpha
3 months ago
Tactile Systems Technology, Inc. (TCMD) Q4 2024 Earnings Call Transcript
Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q4 2024 Earnings Conference Call February 18, 2025 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Max Smock - William Blair Adam Maeder - Piper Sandler Iseult McMahon - BTIG Kyle Bauser - B. Riley Securities Suraj Kalia - Oppenheimer & Company Operator Please standby.
Tactile Systems Technology, Inc. (TCMD) Q4 2024 Earnings Call Transcript
Charts implemented using Lightweight Charts™